Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial

• Published in: The American journal of gastroenterology Vol. 119; no. 7; pp. 1383 - 1391
• Main Authors: Desai, Madhav, Ausk, Karlee, Brannan, Donald, Chhabra, Rajiv, Chan, Walter, Chiorean, Michael, Gross, Seth A., Girotra, Mohit, Haber, Gregory, Hogan, Reed B., Jacob, Bobby, Jonnalagadda, Sreeni, Iles-Shih, Lulu, Kumar, Navin, Law, Joanna, Lee, Linda, Lin, Otto, Mizrahi, Meir, Pacheco, Paulo, Parasa, Sravanthi, Phan, Jennifer, Reeves, Vonda, Sethi, Amrita, Snell, David, Underwood, James, Venu, Nanda, Visrodia, Kavel, Wong, Alina, Winn, Jessica, Wright, Cindy Haden, Sharma, Prateek
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Wolters Kluwer 01.07.2024; Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
• Subjects: Adenoma - diagnosis; Adenoma - diagnostic imaging; Aged; Artificial Intelligence; Cancer; Clinical trials; Colon; Colonic Polyps - diagnosis; Colonic Polyps - diagnostic imaging; Colonic Polyps - pathology; Colonoscopy; Colonoscopy - methods; Colorectal Neoplasms - diagnosis; Early Detection of Cancer - methods; Endoscopy; Female; Histology; Humans; Intention to Treat Analysis; Male; Medical equipment; Middle Aged; Personal computers; Polyps; Predictive Value of Tests; Prospective Studies; Review boards; Software; Statistical analysis; Surveillance; Tumors; United States; United States; CAD-EYE; colonoscopy; artificial intelligence; ADR
• ISSN: 0002-9270; 1572-0241; 1572-0241
• DOI: 10.14309/ajg.0000000000002664

INTRODUCTION:Adenoma per colonoscopy (APC) has recently been proposed as a quality measure for colonoscopy. We evaluated the impact of a novel artificial intelligence (AI) system, compared with standard high-definition colonoscopy, for APC measurement.METHODS:This was a US-based, multicenter, prospective randomized trial examining a novel AI detection system (EW10-EC02) that enables a real-time colorectal polyp detection enabled with the colonoscope (CAD-EYE). Eligible average-risk subjects (45 years or older) undergoing screening or surveillance colonoscopy were randomized to undergo either CAD-EYE-assisted colonoscopy (CAC) or conventional colonoscopy (CC). Modified intention-to-treat analysis was performed for all patients who completed colonoscopy with the primary outcome of APC. Secondary outcomes included positive predictive value (total number of adenomas divided by total polyps removed) and adenoma detection rate.RESULTS:In modified intention-to-treat analysis, of 1,031 subjects (age: 59.1 ± 9.8 years; 49.9% male), 510 underwent CAC vs 523 underwent CC with no significant differences in age, gender, ethnicity, or colonoscopy indication between the 2 groups. CAC led to a significantly higher APC compared with CC: 0.99 ± 1.6 vs 0.85 ± 1.5, P = 0.02, incidence rate ratio 1.17 (1.03-1.33, P = 0.02) with no significant difference in the withdrawal time: 11.28 ± 4.59 minutes vs 10.8 ± 4.81 minutes; P = 0.11 between the 2 groups. Difference in positive predictive value of a polyp being an adenoma among CAC and CC was less than 10% threshold established: 48.6% vs 54%, 95% CI −9.56% to −1.48%. There were no significant differences in adenoma detection rate (46.9% vs 42.8%), advanced adenoma (6.5% vs 6.3%), sessile serrated lesion detection rate (12.9% vs 10.1%), and polyp detection rate (63.9% vs 59.3%) between the 2 groups. There was a higher polyp per colonoscopy with CAC compared with CC: 1.68 ± 2.1 vs 1.33 ± 1.8 (incidence rate ratio 1.27; 1.15-1.4; P < 0.01).DISCUSSION:Use of a novel AI detection system showed to a significantly higher number of adenomas per colonoscopy compared with conventional high-definition colonoscopy without any increase in colonoscopy withdrawal time, thus supporting the use of AI-assisted colonoscopy to improve colonoscopy quality (ClinicalTrials.gov NCT04979962).